Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00694421 · ClinicalTrials.gov registry record
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
A clinical trial, sponsored by Cuneyt M. Alper.
- Completed
- Registry status
- 139
- Enrollment target
NCT00694421: Completed study, sponsored by Cuneyt M. Alper.
NCT00694421 is a clinical trial that has completed, run by Cuneyt M. Alper. The registered enrollment target is 139 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00694421 has completed, sponsored by Cuneyt M. Alper.
- COMPLETED
- Registry status
- 139 participants
- Enrollment target
Study Summary
This study will test the hypothesis that constitutionally poorer Eustachian tube function predisposes to middle-ear pathology during a viral upper respiratory infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-05 |
What the finished NCT00694421 record still lists
NCT00694421 is an observational study that tracks outcomes without assigning an intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00694421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00694421 about?
NCT00694421 is a clinical study titled "Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2". This study will test the hypothesis that constitutionally poorer Eustachian tube function predisposes to middle-ear pathology during a viral upper respiratory infection.
What is the current status of trial NCT00694421?
This trial is currently completed. The enrollment target is 139 participants. The study started on 2008-01. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT00694421?
This trial is sponsored by Cuneyt M. Alper, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia